ASCR_ACREG
ID ASCR_ACREG Reviewed; 512 AA.
AC A0A455R614;
DT 26-FEB-2020, integrated into UniProtKB/Swiss-Prot.
DT 05-JUN-2019, sequence version 1.
DT 25-MAY-2022, entry version 12.
DE RecName: Full=Ascofuranone/ascochlorin biosynthesis clusters transcription regulator {ECO:0000303|PubMed:30952781};
GN Name=ascR {ECO:0000303|PubMed:30952781};
OS Acremonium egyptiacum (Oospora egyptiaca).
OC Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;
OC Hypocreomycetidae; Hypocreales; Hypocreales incertae sedis; Acremonium.
OX NCBI_TaxID=749675;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, INDUCTION,
RP AND PATHWAY.
RC STRAIN=F-1392;
RX PubMed=30952781; DOI=10.1073/pnas.1819254116;
RA Araki Y., Awakawa T., Matsuzaki M., Cho R., Matsuda Y., Hoshino S.,
RA Shinohara Y., Yamamoto M., Kido Y., Inaoka D.K., Nagamune K., Ito K.,
RA Abe I., Kita K.;
RT "Complete biosynthetic pathways of ascofuranone and ascochlorin in
RT Acremonium egyptiacum.";
RL Proc. Natl. Acad. Sci. U.S.A. 116:8269-8274(2019).
RN [2]
RP BIOTECHNOLOGY.
RX PubMed=12084465; DOI=10.1016/s0925-4439(02)00086-8;
RA Nihei C., Fukai Y., Kita K.;
RT "Trypanosome alternative oxidase as a target of chemotherapy.";
RL Biochim. Biophys. Acta 1587:234-239(2002).
RN [3]
RP BIOTECHNOLOGY.
RX PubMed=12798927; DOI=10.1016/s1383-5769(03)00012-6;
RA Yabu Y., Yoshida A., Suzuki T., Nihei C., Kawai K., Minagawa N.,
RA Hosokawa T., Nagai K., Kita K., Ohta N.;
RT "The efficacy of ascofuranone in a consecutive treatment on Trypanosoma
RT brucei brucei in mice.";
RL Parasitol. Int. 52:155-164(2003).
RN [4]
RP BIOTECHNOLOGY.
RX PubMed=20688188; DOI=10.1016/j.parint.2010.07.006;
RA Nakamura K., Fujioka S., Fukumoto S., Inoue N., Sakamoto K., Hirata H.,
RA Kido Y., Yabu Y., Suzuki T., Watanabe Y., Saimoto H., Akiyama H., Kita K.;
RT "Trypanosome alternative oxidase, a potential therapeutic target for
RT sleeping sickness, is conserved among Trypanosoma brucei subspecies.";
RL Parasitol. Int. 59:560-564(2010).
CC -!- FUNCTION: Transcription factor that regulates the expression of the
CC asc-1 and asc-2 gene clusters that mediate the biosynthesis of both
CC ascochlorin and ascofuranone, a strong inhibitor of cyanide-insensitive
CC alternative oxidases and a promising drug candidate against African
CC trypanosomiasis (PubMed:30952781). Binds the 5'-CGGYGNNTTW-3' motif
CC within promoters of the target genes (Probable).
CC {ECO:0000269|PubMed:30952781, ECO:0000305|PubMed:30952781}.
CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00227}.
CC -!- INDUCTION: Expression is induced on AF medium.
CC {ECO:0000269|PubMed:30952781}.
CC -!- BIOTECHNOLOGY: Ascofuranone is a specific inhibitor of trypanosome
CC alternative oxidase (TAO), and quickly kills African trypanosomes in
CC vitro and cures infected mice. As an essential factor for trypanosome
CC survival, TAO is a promising drug target due to the absence of
CC alternative oxidases in the mammalian host.
CC {ECO:0000269|PubMed:12084465, ECO:0000269|PubMed:12798927,
CC ECO:0000269|PubMed:20688188}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; LC406756; BBF25312.1; -; Genomic_DNA.
DR AlphaFoldDB; A0A455R614; -.
DR SMR; A0A455R614; -.
DR GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IEA:InterPro.
DR GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR CDD; cd00067; GAL4; 1.
DR Gene3D; 4.10.240.10; -; 1.
DR InterPro; IPR001138; Zn2-C6_fun-type_DNA-bd.
DR InterPro; IPR036864; Zn2-C6_fun-type_DNA-bd_sf.
DR Pfam; PF00172; Zn_clus; 1.
DR SMART; SM00066; GAL4; 1.
DR SUPFAM; SSF57701; SSF57701; 1.
DR PROSITE; PS50048; ZN2_CY6_FUNGAL_2; 1.
PE 1: Evidence at protein level;
KW DNA-binding; Metal-binding; Nucleus; Transcription;
KW Transcription regulation; Zinc.
FT CHAIN 1..512
FT /note="Ascofuranone/ascochlorin biosynthesis clusters
FT transcription regulator"
FT /id="PRO_0000448997"
FT DNA_BIND 14..49
FT /note="Zn(2)-C6 fungal-type"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00227"
FT REGION 54..87
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 118..148
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 325..351
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 512 AA; 55269 MW; F14D78E599CA23D7 CRC64;
MGNSANEDKL RYACDRCHSQ KLRCPRSVEP EKANPEEPCS RCRKAGVPCV VSLRGKVGRP
SKATKKKSAR SPRATSTPEA EFPPYDINSV LSGEVDGSIP WASPSGDRMM DMFDLASGSG
SVTTSASPKT MAEDYQPEGQ RPFPDPLMGP GLIQVPYEPF LMEFDTDADY PTFCIPPSLT
DMPAGVEFNQ PQDKTFNSSQ MDSFMDVKTD ASMMMPHADM DMTSPKGTGP TIDPVTVDPR
MSFSAHAAQS PGDIFASDDF EAGAEFSSTA SYQKLSDLNL RILQCGSTAQ AGTAPQNSSQ
LLKDVVGFSG ELIDIARQSM PHFVGCTRSS SRASTTSKGS SMESDEGDGS IDTAFSQSSW
GSLKPGSASG PQATSQSVPE SAVIFLLLGC YTQILHLFEL TTNCLWAQHC EAGQPAPQND
DTSGTIGSLL EASIAIHTVT YLLSRLHRAL AAPEMDASTD AADSHGWKKS FVGGKELEDG
LLGRAFGEIR EREQWLMRRT KHLQQRINKC HI